TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Female
KW - Humans
KW - Male
KW - Managed Care Programs
KW - Opioid-Related Disorders/rehabilitation
KW - Prescription Drugs
KW - Psychiatric Status Rating Scales
KW - Residence Characteristics
KW - Socioeconomic Factors
KW - Street Drugs
KW - Treatment Outcome
KW - Young Adult
AU - J. Tkacz
AU - J. Severt
AU - C. Kassed
AU - C. Ruetsch
A1 - 
AB - This study compared the clinical and demographic profiles of three opioid-dependent user groups, and measured their response to 1 year of buprenorphine-medication assisted treatment. Opioid prescription, street, and combination (street + prescription) users completed the Addiction Severity Index multiple times over the course of one treatment year. Although groups differed on all measured demographics (P values <.05) and on six of seven Addiction Severity Index composite scores at induction (P values <.05), differences were ameliorated after 1 year. Findings highlight the disparities between the various opioid-dependent patient subpopulations and suggest that buprenorphine-medication assisted treatment is an effective treatment across user subtypes.
BT - Journal of addictive diseases
C5 - Opioids & Substance Use
CP - 2
CY - England
IS - 2
JF - Journal of addictive diseases
N2 - This study compared the clinical and demographic profiles of three opioid-dependent user groups, and measured their response to 1 year of buprenorphine-medication assisted treatment. Opioid prescription, street, and combination (street + prescription) users completed the Addiction Severity Index multiple times over the course of one treatment year. Although groups differed on all measured demographics (P values <.05) and on six of seven Addiction Severity Index composite scores at induction (P values <.05), differences were ameliorated after 1 year. Findings highlight the disparities between the various opioid-dependent patient subpopulations and suggest that buprenorphine-medication assisted treatment is an effective treatment across user subtypes.
PP - England
PY - 2012
SN - 1545-0848; 1055-0887
SP - 100
EP - 111
EP - 
T1 - Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatment
T2 - Journal of addictive diseases
TI - Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatment
U1 - Opioids & Substance Use
U2 - 22540432
VL - 31
VO - 1545-0848; 1055-0887
Y1 - 2012
ER -